NYSE - Nasdaq Real Time Price USD

Colgate-Palmolive Company (CL)

75.95
+0.97
+(1.29%)
As of 11:22:15 AM EST. Market Open.
Chart Range Bar
Loading chart for CL
  • Previous Close 74.98
  • Open 75.80
  • Bid 75.89 x 60000
  • Ask 75.90 x 30000
  • Day's Range 75.00 - 76.25
  • 52 Week Range 74.55 - 100.18
  • Volume 2,590,941
  • Avg. Volume 5,812,332
  • Market Cap (intraday) 61.221B
  • Beta (5Y Monthly) 0.30
  • PE Ratio (TTM) 21.27
  • EPS (TTM) 3.57
  • Earnings Date Jan 30, 2026
  • Forward Dividend & Yield 2.08 (2.77%)
  • Ex-Dividend Date Oct 17, 2025
  • 1y Target Est 87.26

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, and Soupline brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

www.colgatepalmolive.com

34,000

Full Time Employees

December 31

Fiscal Year Ends

Performance Overview: CL

Trailing total returns as of 11/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CL
14.44%
S&P 500 (^GSPC)
15.62%

1-Year Return

CL
16.90%
S&P 500 (^GSPC)
19.04%

3-Year Return

CL
11.43%
S&P 500 (^GSPC)
80.35%

5-Year Return

CL
1.88%
S&P 500 (^GSPC)
97.49%

Earnings Trends: CL

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized
 

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY25
Revenue 5.13B
Earnings 735M

Q4

FY24

Q1

FY25

Q2

FY25

Q3

FY25

0
1B
2B
3B
4B
5B
 

Analyst Insights: CL

View More

Analyst Price Targets

77.00
87.26 Average
75.95 Current
95.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Latest Rating

Date 11/4/2025
Analyst Barclays
Rating Action Maintains
Rating Equal-Weight
Price Action Lowers
Price Target 82 -> 80
 

Statistics: CL

View More

Valuation Measures

Annual
As of 10/2/2025
  • Market Cap

    63.29B

  • Enterprise Value

    70.83B

  • Trailing P/E

    22.00

  • Forward P/E

    19.80

  • PEG Ratio (5yr expected)

    1.60

  • Price/Sales (ttm)

    3.20

  • Price/Book (mrq)

    90.16

  • Enterprise Value/Revenue

    3.54

  • Enterprise Value/EBITDA

    14.72

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.47%

  • Return on Assets (ttm)

    15.34%

  • Return on Equity (ttm)

    293.64%

  • Revenue (ttm)

    20.1B

  • Net Income Avi to Common (ttm)

    2.91B

  • Diluted EPS (ttm)

    3.57

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.47B

  • Total Debt/Equity (mrq)

    680.05%

  • Levered Free Cash Flow (ttm)

    2.74B

Compare To: CL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights: CL

Fair Value

75.95 Current
 

Dividend Score

0 Low
Sector Avg.
100 High
 

Hiring Score

0 Low
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
Sector Avg.
100 High
 

Research Reports: CL

View More
  • Colgate Earnings: Despite a Halt in Sales Growth, Brand Prowess Persists; Shares a Bargain

    Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for north of 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one-fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.

    Rating
    Price Target
     
  • Large Cap US Pick List - October 2025

    This pick list highlights constituents of the Morningstar US Large Cap Index that we believe offer investors the best risk-adjusted return prospects. Stocks of large-cap companies where neither growth nor value characteristics predominate. Stocks in the top 70% of the capitalization of the U.S. equity market are defined as large cap.

     
  • With a Stringent Eye on Cost Management, Colgate Stands to Buttress Its Competitive Edge

    Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for north of 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one-fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.

    Rating
    Price Target
     
  • Large Cap US Pick List - September 2025

    This pick list highlights constituents of the Morningstar US Large Cap Index that we believe offer investors the best risk-adjusted return prospects. Stocks of large-cap companies where neither growth nor value characteristics predominate. Stocks in the top 70% of the capitalization of the U.S. equity market are defined as large cap.

     

People Also Watch